Literature DB >> 8657948

Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.

Y Yamashita1, K Mitsuzaki, T Yi, I Ogata, T Nishiharu, J Urata, M Takahashi.   

Abstract

PURPOSE: To compare contrast material-enhanced dynamic magnetic resonance (MR) imaging with helical computed tomography (CT) for the detection of small hepatocellular carcinoma (HCC) in patients with chronic liver damage.
MATERIALS AND METHODS: Fifty patients with chronic hepatitis or liver cirrhosis underwent dynamic contrast-enhanced fast low-angle shot MR imaging and multiple-phase helical CT. Arterial, portal-venous, and delayed-phase images were compared. Diagnostic ability with both techniques was evaluated by means of receiver operating characteristic (ROC) analysis; images in patients with (n = 27) and those without (n = 15) HCC in whom the same anatomic levels were available for both examinations were assessed. Seventy-two lesions were evaluated, and tumor diameter ranged from 0.5 to 3.0 cm (mean, 1.9 cm).
RESULTS: ROC analysis showed that the arterial-phase images obtained with both techniques allowed better detection of HCC. Diagnostic ability was significantly better with arterial-phase MR imaging (mean area under the ROC curve [Az] = 0.96) than arterial-phase CT (Az = 0.87) or with images from any other phase (P < .05). For the delayed phase, diagnostic capability was significantly better with CT (Az = 0.84) than with MR imaging (Az = 0.77) (P < .05).
CONCLUSION: Arterial-phase dynamic MR imaging is superior to helical CT for the detection of HCC in patients with chronic liver damage.

Entities:  

Mesh:

Year:  1996        PMID: 8657948     DOI: 10.1148/radiology.200.1.8657948

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.

Authors:  Katsutoshi Sugimoto; Fuminori Moriyasu; Junji Shiraishi; Kazuhiro Saito; Junichi Taira; Toru Saguchi; Yasuharu Imai
Journal:  Eur Radiol       Date:  2012-01-24       Impact factor: 5.315

2.  Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.

Authors:  Hong Zhao; Jin-Lin Yao; Ying Wang; Kang-Rong Zhou
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

3.  Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma.

Authors:  Seishi Kumano; Masahiko Uemura; Toyoaki Haraikawa; Masaaki Hirata; Keiichi Kikuchi; Tonsok Kim; Masahiro Okada; Teruhito Mochizuki; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2009-07-22       Impact factor: 2.374

4.  Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Kensuke Uotani; Koji Sugimoto; Masahiko Fujii; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-30       Impact factor: 5.315

5.  Evaluation of transcatheter arterial embolization therapy on hepatocellular carcinomas using contrast-enhanced harmonic power Doppler sonography: comparison with CT, power Doppler sonography, and dynamic MRI.

Authors:  Toshihide Shima; Masayuki Mizuno; Hideaki Otsuji; Chiemi Mizuno; Hirozumi Obata; Hyohun Park; Shinobu Nakajo; Takeshi Okanoue
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

Review 6.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

7.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

Review 8.  Hepatocellular carcinoma.

Authors:  S Badvie
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

9.  Graphics Processing Unit-Accelerated Nonrigid Registration of MR Images to CT Images During CT-Guided Percutaneous Liver Tumor Ablations.

Authors:  Junichi Tokuda; William Plishker; Meysam Torabi; Olutayo I Olubiyi; George Zaki; Servet Tatli; Stuart G Silverman; Raj Shekher; Nobuhiko Hata
Journal:  Acad Radiol       Date:  2015-03-14       Impact factor: 3.173

10.  Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Young-Kon Kim; Young Hwan Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.